When systemically injected, Epi-1-LNPs carrying PLK1 siRNA achieved significant inhibition of PLK1 gene expression at tumor sites in a Hep3B xenograft cancer model (Sakurai et al.2017) and an ovarian cancer peritoneal dissemination model (Sakurai et al.2020). Here, PLK1 is linked to cancer.